Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Tags:
Bristol-Myers Squibb, Opdivo, Merck, Cubist Pharmaceuticals, Zerbaxa, AstraZeneca, Lynparza, Novo Nordisk, Saxenda
FDA approves Novo Nordisk's Saxenda, an injectable weight-loss treatment
Yahoo/AP
Wed, 12/24/14 - 08:44 am
Tags:
Novo Nordisk, FDA, Saxenda, obesity, liraglutide
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:29 am
Tags:
diabetes, obesity, Arena Pharmaceuticals, Novo Nordisk, AstraZeneca, Orexigen, Vivus, Farxiga, Victoza, Invokana
Diabetes: The Global Epidemic Pushing Novo Nordisk Higher
Seeking Alpha
Sat, 11/29/14 - 12:37 pm
Tags:
diabetes, Novo Nordisk
Novo Nordisk's Victoza receives positive opinion for use in adults with type 2 diabetes
Reuters
Fri, 11/21/14 - 10:41 am
Tags:
Novo Nordisk, type 2 diabetes, diabetes, Victoza
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Tags:
Sovaldi, Gilead Sciences, Eyelea, Tecfidera, Zytiga, Kalydeco, Vertex Pharmaceuticals, Victoza, Novo Nordisk, Gilenya, Yervoy, Xtandi, Stribild, Stelara
Novo Nordisk builds blockbuster case with promising PhIII obesity data
Fierce Biotech
Tue, 11/4/14 - 10:39 am
Tags:
Novo Nordisk, obesity, liraglutide
Novo Nordisk reassures on 2015 outlook after Sanofi jolt
Yahoo/Reuters
Thu, 10/30/14 - 09:23 am
Tags:
Novo Nordisk, Sanofi, Tresiba
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Mon, 10/6/14 - 11:51 am
Tags:
Sanofi, Novo Nordisk, basal insulin, diabetes, Lantus, Levemir
Novo Nordisk Establishes New Obesity Research Unit
Drug Discovery and Development
Mon, 09/29/14 - 01:17 pm
Tags:
Novo Nordisk, obesity, R&D
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes
Yahoo/Zacks.com
Tue, 09/23/14 - 07:46 am
Tags:
Novo Nordisk, Xultophy, diabetes, Tresiba, Victoza
Are obesity drugs nearing a breakout? Novo, Takeda think so
Fierce Pharma
Thu, 09/18/14 - 09:18 am
Tags:
Novo Nordisk, Takeda, obesity, Saxenda
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Bidness Etc.
Wed, 09/17/14 - 04:53 pm
Tags:
Sanofi, Novo Nordisk, diabetes, insulin, Lantus, Tresiba, Toujeo
Novo May Add Hundreds to R&D Staff for Obesity Medicines
Bloomberg
Wed, 09/17/14 - 08:38 am
Tags:
Novo Nordisk, R&D, hirings, Saxenda, obesity
Study shows Novo's new diabetes drug effective and safe for children
Yahoo/Reuters
Tue, 09/16/14 - 12:11 pm
Tags:
Novo Nordisk, diabetes, pediatric, insulin, Tresiba
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Mon, 09/15/14 - 10:10 am
Tags:
Bristol-Myers Squibb, Merck, GSK, Novo Nordisk, Sanofi, Novartis, Pfizer, Biogen Idec, Roche
Novo’s Weight-Loss Shot Wins Backing of U.S. Advisers
Bloomberg
Thu, 09/11/14 - 04:44 pm
Tags:
Novo Nordisk, FDA, obesity, vaccines, Saxenda, liraglutide
FDA staff: Novo Nordisk drug liraglutide effective for obesity
Yahoo/Reuters
Tue, 09/9/14 - 10:03 am
Tags:
FDA, Novo Nordisk, liraglutide, obesity, Victoza
More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tue, 09/9/14 - 08:08 am
Tags:
obesity, Orexigen, Novo Nordisk, NB32, liraglutide, Victoza, Takeda
Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists
Forbes
Thu, 09/4/14 - 08:29 am
Tags:
Piramal Healthcare, Exelixis, Novo Nordisk, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.